Steroid sensitive nephrotic syndrome (SSNS) is considered a relatively benign condition, as progression to end stage renal failure is extremely rare and approximately 80% of child will enter long term remission. 1, 2 Idiopathic nephrotic syndrome in childhood is diagnosed by the presence of significant proteinuria. hypoalbuminaemia and oedema, the underlying cause of which is unknown and minimal changes on renal biopsy by light microscopy. No immunoglobulin (Ig) or complement fraction deposit is seen on immunofluorescence examination.
Idiopathic nephrotic syndrome in childhood is diagnosed by the presence of significant proteinuria. hypoalbuminaemia and oedema, the underlying cause of which is unknown and minimal changes on renal biopsy by light microscopy. No immunoglobulin (Ig) or complement fraction deposit is seen on immunofluorescence examination.
Minimal change disease has become synonymous with steroid sensitive nephrotic syndrome as renal biopsy is not usually performed when the patient responds to corticosteroids.
However some patients who responds to corticosteroids shows diffuse mesangialproliferation or focal and segmental glomerulosclerosis (FSGS). Moreover, in the early stages, FSGS and minimal change disease are. 2, 3 The annual incidence in the west is about 3 new cases per 100,000 child population, Asians have a higher incidence, about 16 new cases per 100,000 child population. 4 The nephrotic syndrome is 15 times more common in children than adults. 5 Although there is no available local data, it is felt that the incidence in Bangladesh is also higher than in the west. The cause of SSNS is unknown, although the prevalence is higher in atopic families and abnormalities of the cell function. 6, 7 The albumin leak may be the consequence of loss of anionic changes in the glomerular basement membrane.
The nephrotic syndrome is characterized by massive protenuria (3+ or 4+ protein or 40 mg/m 2 /hr or 50mg/kg/d) hypoabuminemia <25g/dl and oedema. Hyperlipidaemia is invariably present. Urinary Protein 3+/4+(on dipstick or boiling test) is adequate for defining nephrotic range proteinuria, precise quantification with 24 hours protein in urine is not required for diagnosis. There is excellent correlation with the early morning urine protein (or albumin/createnine ratio of exceeds 200mg/m.mol in nephrotic patient. 8 Timed urine collections are difficult in children.
Management of Steroid Sensitive Idiopathic Nephritic
Syndrome in Children GM UDDIN
Summary:
Minimal change disease has become synonymous with steroid sensitive nephrotic syndrome as most of them achieve remission with corticosteroid therapy. Nephrotic syndrome is a common chronic disorder in children characterized by minimal change disease in majority. Despite being one of the most common renal conditions encountered in paediatric practice significant questions regarding treatment remain unanswered. Recent data from reviews shows that increased duration ( Other investigations depends on the clinical features and the physician in charge.
The international study of kidney Disease in children (ISKDC) had found that at the initial presentation of children with minimal change nephrotic syndrome. 10 20.7% of children had systolic blood pressure above 98th percentile for age , 22.7% had microscopic haematuria, 32.5% had transiently raised plasma creatinine concentration.
Management:
Of the oedematous state:
A. Bed rest: This is not required unless the child has grossly oedematous genitalia may restrict his or her activity because of discomfort.
B. Diet: A normal protein diet with adequate calories. Salt intake should be restricted 1 2 gm/ day. If there is malnutrition due to persistent proteinuria then patient should receive 2 2.5g/kg proteins daily. A reduction of saturated fat is advisable.
C. Antibiotics: Prophylactic of S pneumonia with oral penicillin at doses of 125 mg B.D, or 250mg B.D till edema persists is prescribed to children. 11 Pneumococcal vaccine can be considered.
D. Hypovolaemia: Children with nephrotic syndrome can present with hypovolaemia, manifests with abdominal pain, cold peripheries, poor pulse volume, hypotension and haemoconcentration. A rapid infusion of plasma (purified protein fraction)20/ml/kg or more. Salt poor albumin 1/gm/kg body weight as 20% solution over 1-2 hours followed by frusemide 1-2 mg/kg. 12, 13 E. Fluid restriction: Is recommended in severe oedema with Respiratory distress and if plasma sodium <125moml /L (300ml/m2/day + previous day urine output).
F. Diuretics: Symptomatic grossly oedematous states with salt poor albumin of 20-25% with frusemide 1-2 mg/kg.Patients requiring higher doses and prolonged duration should be treated with frusemide along with spironolactone (dose 2-4 mg/kg daily). There is however, danger of fluid overload so child's urine output and blood pressure should be closely monitored. The international study for kidney Diseases in children had originally recommended four weeks each of daily and alternate day steroid therapy, which was almost universally used until recently. 14 Arbeitsgemeinschaft fur Paediatrische Nephrologic (APN) has shown significant reduction in relapse after initial treatment of 60mg/m 2 /d for 6 weeks followed by alternate day 40 mg/m 2 for 6 weeks. 15, 16 Longer initial steroid regime proposed and studied by Ueda et al, and ksiazek & Wysznska, Joyantha who showed a 2 year relapse free rate for the long initial prednisolone dose versus 27.5% for the modified ISKDC regime. 17, 18, 19 Long Initial prednisolone regiem: Prednisolone dosage at: 60mg/m 2 /day (maximum 80mg/day) for 4 weeks & 40 mg/m 2 /24 hours for 4 weeks, reduced by 25% monthly over the next 4 months. 17 The children in their first episode of SSNS, treatment with prednisolone for at least 3 months result in fewer children relapsing by 12 to 24 months with increases in benefit being demonstrated for up to seven months of treatment compared with two months therapy. 20 The choice of using either regime left to the individual attending paediatrician.
A child with nephritic syndrome who fails to respond to initial four-week treatment with corticosteroids should be referred to a paediatric nephrologist for renal biopsy.
Relapse: A relapse is defined by albumin excretion of >40 mg/m2 /hr or urine dipsticks of 2 + or more for 3 consecutive days.
Treatment of relapse: The ISKDC proposed that relapsing and steroid dependent SSNS should be treated with daily prednisolone 60mg/m 2 /day till the child had been in remission for 3 days followed by 4 weeks of prednisolone given 3 consecutive days out of 7. More recently, alternate day therapy has been preferred. 21 The risk of relapse was significantly reduced if children are treated for 7 months compared with modified ISKDC regimen. 19, 20 Frequent relapses and steroid dependence:
In initial responder who has 2 or more relapses within 6 months of initial response or 4 or more relapses in any 12 months period is said to be have frequent relapses.
Reinduction of any relapse with corticosteroids as before and after 4 weeks, dose is tapered to continue alternate day of 0.5 mg /kg or lower up to 7 months. The number of children with frequent relapse are also decreased with a longer initial course of prednisolone. The relative risk decreased by 0. 133 (13%) for every additional month of treatment up to 7 months. 22 Alternative treatment:-(Non-Steroidal therapies)
There is not complete agreement about the precise stage at which alternative treatment to corticosteroid should be introduced. It is not necessary to perform renal biopsy at this situation.
Alternative treatment for SSNS should be considered in the following circumstances: Treatment with prednisolone 1.5 mg/kg on alternate days is continued along with. The dose of prednisolone is gradually reduced by 0.15 0.25 mg/kg every 4 weeks to maintenance dose of 0.25 mg/kg, which is to be continued for 6 months. The number of relapses reduced to an equivalent extent by levamisole treatment given for 6 months or more or cyclophosphamide given for 8-12 weeks. 26 (b) Alkylating agents: Alkaylating agents impaired DNA transcription are cyclophosphamide and chlorambucil. Cyclophosphamide is a potent steroid sparing agent, which induces sustained remission in 53% of children for I year. 23, 24 Indications are, steroid toxicity, severe relapse with hypovolaemia and thrombosis and poor compliance on follow up. If patient relapses on prednisolone > 1 mg/kg/day or after steroid toxicity >0.5mg/kg/day alternate day. The dose of cyclophosphamide is 2-3 mg/kg /day, alternate day a prednisolone (1-1.5 mg/kg) for 8-12 weeks. A total cumulative dose of cyclophosphamide 168 mg/kg. Early side effects include bone marrow suppression, alopecia, GI upset and haemorrhagic cystitis. Late: Infertility and malignancy. There were few data on chlorambucil.
Post cyclophosphamide relapse should be treated with prednisolone and second course of cyclophosphamide if one year had relapsed after the first course or with cyclosporine. Hypovolaemia: Rapid loss of protein lead to hypovolaemia if accompanied by septicaemia, diarrhoea or injudicious use of diuretics. Hypovolaemia should be rapidly corrected with infusion saline, plasma (20 ml/kg) or albumin (20 %,1gm/kg) given over 1-2 hours followed by frusemide 1mg/kg. Hypertension: Hypertension 'should be managed with salt and fluid restriction, and if necessary with anti hypertensives such as beta blockers, calcium channel blockers ACE inhibitors.
Acute renal failure: The actual cause is not known although hypovolemia and sepsis has been implicated .Intrarenal factors have also been postulated to play a role. Renal failure may be secondary to bilateral renal vein thrombosis or interstitial nephritis. Acute renal failure is reversibile often with intravenous albumin and high dose frusemide on dialysis may be required.
Steroid during Stress:
Suppression of hypothalamopituitary axis may occur with prednisolone >1mg/kg/day for >2 weeks in the preceding 3 6 months. Stress doses of steroid, hydrocortisone 30 50 mg/m 2 or prednisolone I mg/kg/day for the duration of stress is indicated.
Conclusion:
The prognosis of steroid sensitive nephrotic syndrome is excellent. The disease is characterized by relapses and remission. Education of parents and patients how to regularly monitor the urine and how to record the results in a diary is most important.
The long term prognosis for most Children with steroid sensitive nephrotic syndrome (SSNS) is for resolution of their disease and maintenance of normal renal function. Approxemately 80% of children with SSNS will relapse one or more times. Of those, 50% relapse frequently or become steroid dependent. 29 The frequency of relapses decreases with time with 50-70% of children being relapse-free at 5 years and about 85% relapse free at 10 years. 29 
